A Prostate Cancer Unit is a place where men can be cared for by specialists in prostate cancer (PC), working together within a multi-disciplinary team (MDT). The MDT approach guarantees a higher probability for the PC patient to receive adequate information on the disease and on all possible therapeutic strategies, balancing advantages and related side effects. Objecive: To analyze the role of a MDT in PC management and to compare some results in terms of characteristics and distribution of PC cases, obtained by a MDT, with those reported by a monodisciplinary urological unit. Outcome measurements and results: A high percentage of cases (47.6%) referred to our MDT were in the low risk group. In the Prostate cancer Unit the indications for p...
AIMS AND BACKGROUND: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
The use of multidisciplinary team (MDT) meetings have proven benefits in cancer care. In this thesi...
Objectives: The initial treatment decision for newly diagnosed non-metastatic prostate cancer is com...
Prostate cancer (PC) is established as one of the most important medical problems affecting the male...
Keeping current with medical innovations is a challenge that all health care professionals are faced...
The prostate cancer is a complex pathology involving oncological, functional and psychosocial items....
The widely recognised benefits of a multidisciplinary approach to treating cancer may be particularl...
Decision-making in the management of organ-confined prostate cancer is complex as it is based on mul...
The multidisciplinary team (MDT) is defined as a group of people of different healthcare disciplines...
The diagnosis of prostate cancer (PCa) often represents a stressful event. In addition to the psycho...
Kazuhiro Watanabe,1,* Gen Kawaguchi,2,* Yohei Ikeda,3 Noboru Hara,1 Tsutomu Nishiyama1 1Depa...
Purpose: Previous studies indicate that a multidisciplinary ap-proach could be suitable for dealing ...
The Belgian oncology care system has been the subject of a major reorganization in recent years. The...
Aims and background. The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
Purpose: Previous studies indicate that a multidisciplinary approach could be suitable for dealing w...
AIMS AND BACKGROUND: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
The use of multidisciplinary team (MDT) meetings have proven benefits in cancer care. In this thesi...
Objectives: The initial treatment decision for newly diagnosed non-metastatic prostate cancer is com...
Prostate cancer (PC) is established as one of the most important medical problems affecting the male...
Keeping current with medical innovations is a challenge that all health care professionals are faced...
The prostate cancer is a complex pathology involving oncological, functional and psychosocial items....
The widely recognised benefits of a multidisciplinary approach to treating cancer may be particularl...
Decision-making in the management of organ-confined prostate cancer is complex as it is based on mul...
The multidisciplinary team (MDT) is defined as a group of people of different healthcare disciplines...
The diagnosis of prostate cancer (PCa) often represents a stressful event. In addition to the psycho...
Kazuhiro Watanabe,1,* Gen Kawaguchi,2,* Yohei Ikeda,3 Noboru Hara,1 Tsutomu Nishiyama1 1Depa...
Purpose: Previous studies indicate that a multidisciplinary ap-proach could be suitable for dealing ...
The Belgian oncology care system has been the subject of a major reorganization in recent years. The...
Aims and background. The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
Purpose: Previous studies indicate that a multidisciplinary approach could be suitable for dealing w...
AIMS AND BACKGROUND: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
The use of multidisciplinary team (MDT) meetings have proven benefits in cancer care. In this thesi...
Objectives: The initial treatment decision for newly diagnosed non-metastatic prostate cancer is com...